Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr 16;382(16):1573-1574.
doi: 10.1056/NEJMc2000644.

PARP Inhibitors in Ovarian Cancer

Tim J A Dekker  1
Affiliations
Comment

PARP Inhibitors in Ovarian Cancer

Tim J A Dekker. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment in

  • PARP Inhibitors in Ovarian Cancer. Reply.
    Ray-Coquard I, Pérol D, Pujade-Lauraine E. Ray-Coquard I, et al. N Engl J Med. 2020 Apr 16;382(16):1574-1575. doi: 10.1056/NEJMc2000644. N Engl J Med. 2020. PMID: 32294365 No abstract available.

Comment on

  • Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
    Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.

LinkOut - more resources